Oyster Point Pharma, Inc.
SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE
Last updated:
Abstract:
The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.
Status:
Application
Type:
Utility
Filling date:
14 Aug 2019
Issue date:
2 Jul 2020